138 related articles for article (PubMed ID: 29874113)
1. Rs2303428 of MSH2 Is Associated with Hepatocellular Carcinoma Prognosis in a Chinese Population.
Zhu X; Wang Z; Qiu X; Wang W; Bei C; Tan C; Qin L; Ren Y; Tan S
DNA Cell Biol; 2018 Jul; 37(7):634-641. PubMed ID: 29874113
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
[TBL] [Abstract][Full Text] [Related]
3. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between hepatocellular carcinoma and the interaction between hMSH2 polymorphisms and environmental factors].
Tan S; Wang W; Liu S; Wei Q; Wei J; Wang Z; Yan M; Qiu X
Zhonghua Gan Zang Bing Za Zhi; 2014 Sep; 22(9):676-9. PubMed ID: 25369252
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
6. Associations between single nucleotide polymorphisms in RYBP and the prognosis of hepatocellular carcinoma in a Chinese population.
Zhu X; Wang Z; Qiu X; Tan C; Yu H; Bei C; Qin L; Ren Y; Tan S
Carcinogenesis; 2017 May; 38(5):532-540. PubMed ID: 28369212
[TBL] [Abstract][Full Text] [Related]
7. The influence of caveolin-1 gene polymorphisms on hepatitis B virus-related hepatocellular carcinoma susceptibility in Chinese Han population: A case-control study.
Zhang J; Xue F; Chen S; Zhang D; Lu C; Tang G
Medicine (Baltimore); 2017 Oct; 96(42):e7359. PubMed ID: 29049173
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphism of rs430397 in the fifth intron of GRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese: risk and prognosis.
Zhu X; Chen MS; Tian LW; Li DP; Xu PL; Lin MC; Xie D; Kung HF
Int J Cancer; 2009 Sep; 125(6):1352-7. PubMed ID: 19533686
[TBL] [Abstract][Full Text] [Related]
9. Association of CD44 polymorphisms and susceptibility to HBV-related hepatocellular carcinoma in the Chinese population.
Deng Y; Chen ZJ; Lan F; He QT; Chen SY; Du YF; Li S; Qin X
J Clin Lab Anal; 2019 Oct; 33(8):e22977. PubMed ID: 31301090
[TBL] [Abstract][Full Text] [Related]
10. Nonreceptor protein tyrosine phosphatases (NRPTPs) gene family associates with the risk of hepatocellular carcinoma in a Chinese hepatitis B virus-related subjects.
Shen N; Wang P; Li Y; Zhu Y; Gong Y; Zhong R; Lu Y; Cheng L
Mol Carcinog; 2020 Aug; 59(8):980-988. PubMed ID: 32484301
[TBL] [Abstract][Full Text] [Related]
11. Genetic biomarkers for hepatocellular cancer risk in a caucasian population.
De Mattia E; Cecchin E; Polesel J; Bignucolo A; Roncato R; Lupo F; Crovatto M; Buonadonna A; Tiribelli C; Toffoli G
World J Gastroenterol; 2017 Sep; 23(36):6674-6684. PubMed ID: 29085212
[TBL] [Abstract][Full Text] [Related]
12. [Genetic variations in MLH3 and MSH2 genes are associated with the sensitivity and prognosis in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy].
Yang J; Wang X; Zou SM; Li HM; Xiao Q; Feng YR; Huang Y; Feng T; Chen JN; Lin DX; Li YX; Jin J; Tan W
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):433-440. PubMed ID: 29936769
[No Abstract] [Full Text] [Related]
13. Toll-like receptor 3 genetic variants and susceptibility to hepatocellular carcinoma and HBV-related hepatocellular carcinoma.
Li G; Zheng Z
Tumour Biol; 2013 Jun; 34(3):1589-94. PubMed ID: 23404408
[TBL] [Abstract][Full Text] [Related]
14. Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.
Liu L; An J; Liu J; Wen J; Zhai X; Liu Y; Pan S; Jiang J; Wen Y; Liu Z; Zhang Y; Chen J; Xing J; Ji G; Shen H; Hu Z; Fan Z
Mol Carcinog; 2013 Nov; 52 Suppl 1():E148-54. PubMed ID: 23868705
[TBL] [Abstract][Full Text] [Related]
15. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
16. Associations between single-nucleotide polymorphisms of human exonuclease 1 and the risk of hepatocellular carcinoma.
Tan S; Qin R; Zhu X; Tan C; Song J; Qin L; Liu L; Huang X; Li A; Qiu X
Oncotarget; 2016 Dec; 7(52):87180-87193. PubMed ID: 27894089
[TBL] [Abstract][Full Text] [Related]
17. SNP-SNP and SNP-environment interactions of potentially functional HOTAIR SNPs modify the risk of hepatocellular carcinoma.
Zhang J; Liu L; Lin Z; Ji X; Pi L; Lin X; Tian N; Liu G; Liu Q; Lin Z; Chen S; Yu X; Gao Y
Mol Carcinog; 2019 May; 58(5):633-642. PubMed ID: 30556621
[TBL] [Abstract][Full Text] [Related]
18. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
19. PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population.
Huang L; Mo Z; Lao X; Zhang X; Liu Y; Sui J; Qin X; Li S
Tumour Biol; 2016 May; 37(5):6599-606. PubMed ID: 26643892
[TBL] [Abstract][Full Text] [Related]
20. The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis.
Qin S; Wang J; Zhou C; Xu Y; Zhang Y; Wang X; Wang S
Medicine (Baltimore); 2019 Sep; 98(38):e17275. PubMed ID: 31568008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
